The influence of antidotal treatment of low-level tabun exposure on cognitive functions in rats using a water maze

. 2006 Jan ; 9 (1) : 39-45.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid16464751

In this study, the influence of antidotal treatment of tabun poisoning on cognitive function, in the case of low-level tabun exposure, was studied. The impairment of cognitive function was evaluated by the measurement of spatial learning and memory in rats poisoned with a sublethal dose of tabun and treated with atropine alone or in combination with newly developed oximes {K027 [1-(4-hydroxyiminomethyl- pyridinium)-3-(4-carbamoylpyridinium) propane dibromide] and K048 [1-(4-hydroxyimino- methylpyridinium)-3-(4-carbamoylpyridinium) butane dibromide]} or currently available oxime (trimedoxime), using the Morris water maze. While atropine alone caused an impairment of studied cognitive functions, the addition of an oxime to atropine contributes to the improvement of cognitive performance of treated tabun-poisoned rats regardless of the type of oxime. The differences in the ameliorative effects of oximes on atropine-induced mnemonic deficits were not significant. Therefore, each low-level nerve agent exposure should be treated by complex antidotal treatment consisting of anticholinergic drug and oxime.

Zobrazit více v PubMed

Neurosci Lett. 2003 Jul 17;345(2):97-100 PubMed

Acta Medica (Hradec Kralove). 1998;41(3):99-108 PubMed

Toxicol Lett. 1988 Jan;40(1):47-56 PubMed

Adv Clin Chem. 2004;38:151-216 PubMed

Bioorg Med Chem Lett. 2003 Oct 20;13(20):3545-7 PubMed

Brain Res Brain Res Rev. 2003 Mar;41(2-3):268-87 PubMed

J Exp Anal Behav. 1994 Mar;61(2):319-29 PubMed

Neurotoxicology. 2002 May;23(1):7-17 PubMed

Arch Toxicol. 2000 May;74(3):165-72 PubMed

J Toxicol Clin Toxicol. 2002;40(6):803-16 PubMed

J Neurosci Methods. 1984 May;11(1):47-60 PubMed

J Appl Toxicol. 1998 Nov-Dec;18(6):393-408 PubMed

Toxicol Lett. 1996 Apr;85(1):35-9 PubMed

Science. 1982 Jul 30;217(4558):408-14 PubMed

Neurobiol Learn Mem. 1997 Jul;68(1):32-41 PubMed

Pharmacol Biochem Behav. 2001 Sep;70(1):175-9 PubMed

Neurobiol Aging. 2004 Feb;25(2):223-9 PubMed

Behav Brain Res. 2004 May 5;151(1-2):277-86 PubMed

Behav Neural Biol. 1994 May;61(3):260-70 PubMed

Pharmacol Ther. 1993;58(1):51-66 PubMed

Behav Pharmacol. 2001 Jul;12(4):285-92 PubMed

Neurobiol Aging. 1995 Mar-Apr;16(2):149-60 PubMed

Drug Chem Toxicol. 1995 May-Aug;18(2-3):119-36 PubMed

Neurobiol Learn Mem. 2003 Nov;80(3):332-42 PubMed

Trends Cogn Sci. 1999 Sep;3(9):351-359 PubMed

Behav Neurosci. 1996 Oct;110(5):998-1005 PubMed

Horm Behav. 1998 Oct;34(2):149-62 PubMed

Neurotoxicology. 2001 Feb;22(1):29-37 PubMed

Brain Res. 2000 Nov 3;882(1-2):9-18 PubMed

Integr Physiol Behav Sci. 1992 Jul-Sep;27(3):216-27 PubMed

Neurotox Res. 2004;6(7-8):615-30 PubMed

Toxicol Sci. 2003 Sep;75(1):108-16 PubMed

Arch Toxicol. 2003 Aug;77(8):452-8 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...